The same terms could be applied to what's actually in CBD products. While some do contain CBD, others (often marketed as "CBD-rich hemp oil") may have barely any, Asquith says. And depending on state laws, they can include varying levels of THC too – a combination shown to have some benefits, but also drawbacks, of course, if you're not looking for a high. "People will play all these games with the numbers because the consumers aren't really educated in this space yet and it's easy to get taken advantage of," he says. "It's the milligrams of the actual CBD molecule that matter."
With the variety of CBD concentrations and other compounds that hemp offers, full spectrum CBD products can cover all ground. If we were to directly compare the two, scientists point out that full spectrum CBD works with the endocannabinoid system entirely. Isolate products, such as crystal, the highest quality cannabidiol and natural ingredients, and will deliver the most amount of CBD to your system at once. Ultimately, preference is subjective to the user’s condition and system.
'If the Patient Information Leaflet that comes with your medication says to avoid grapefruit juice, for instance, then do not take CBD, as the same type of interaction can affect circulating blood levels of your medicine. Even if the leaflet does not mention grapefruit juice, you should still check with your doctor before taking CBD. You should also not take CBD if you are pregnant or breastfeeding.’
Supercritical CO2 extraction is also the key to understanding more cannabinoids in cannabis like Cannabichromene (CBC) and cannabicitran (CBT) and how they interact with each other (called the Entourage effect). This can lead to increased understanding of marijuana in the medical field, and will also allow growers to come up with more effective, new and exciting strains.
Zuardi, A. W., Crippa, J. A., Hallak, J. E., Bhattacharyya, S., Atakan, Z., Martin-Santos, R., … & Guimarães, F. S. (2012). A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation [Abstract]. Current Pharmaceutical Design, 18(32), 5,131–5,140. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/22716160